Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Dihydroartemisinin. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103180325A reveals high-yield beta-artemether synthesis. Enhances supply chain reliability and reduces manufacturing costs for global pharmaceutical buyers.
Patent CN103664985A details a novel acid-catalyzed route for high-purity beta-hydroxy artemisinyl ether, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN1049435C details novel artemisinin derivatives with phenyl radicals. Discover cost-effective synthesis routes and supply chain advantages for API manufacturing.
Patent CN102267973B details a novel artemisinin intermediate synthesis using hydrogen peroxide, offering significant cost reduction and scalability advantages for pharmaceutical manufacturing.